Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries

Alsammani, Mohamed Alkhatim

doi:10.1007/s12639-014-0558-8

Cited by 33 publications

(38 citation statements)

References 82 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Contrary to this study, data presented by Shao et al [13] showed that gestational age was a significant risk factor. The highest seroprevalence of Toxoplasma antibodies (29.2%) was found in pregnant women at the first trimester is similar to the result of Alsammani [35] contrary to second and third semesters [4,24].…”

Section: Discussionsupporting

confidence: 73%

See 1 more Smart Citation

Socio-demographic and Obstetric Variations of T. gondii and HIV-1 Co-infection among Pregnant Women in Cameroon

Abongwa

Signang

Tibi

et al. 2019

JAMB

View full text Add to dashboard Cite

Aim: This study, aimed to identify the seroprevalence of T. gondii and HIV-1 co-infection in pregnant women in the Northwest Region of Cameroon. Study Design: This cross-sectional study was conducted among 606 pregnant women attending antenatal clinic in the Northwest region of Cameroon. Place and Duration of Study: This study was carried out at the Bamenda Regional Hospital from May 2017 to December 2017. Methodology: Venous blood samples were collected for the detection of anti-Toxoplasma antibodies using rapid test kits while HIV was determine using Alere Determine™HIV-1/2 test kit and OraQuick HIV 1/2 Rapid Antibody Test kit for confirmation. Data were analyzed using SPSS version 23 statistical package. P-value <0.05 was considered statistically significant. Results: The mean (SD) age was 27.3 (5.3) years. The prevalence of T. gondii and HIV-1 was 139 (22.9%) and 70(11.6%) respectively, while that of T. gondii and HIV-1 co-infection was 31(5.1%). With the exception of age group and gestational age that was significant (p<0.05) for HIV, socio-demographic and obstetrical characteristics of T. gondii, HIV-1 and T. gondii and HIV-1 co-infection prevalence did not show any significant differences (p>0.05). Conclusions: The high prevalence of T. gondii and HIV-1 co-infection seen in this study demonstrates the need for routine antenatal screening for both infections. In addition, data from this study will be useful in designing control and prevention strategies against these diseases. Furthermore, the result will also be used as baseline data for further research on T. gondii and HIV-1 co-infection.

show abstract

Section: Discussionsupporting

confidence: 73%

“…Other studies have reported that the risk of contracting T. gondii infection increases with age unlike the case in this study [34,35]. Though age was not a risk factor to the T. gondii infection, younger women <21 years were more infected compared to older women.…”

Section: Discussioncontrasting

confidence: 66%

Socio-demographic and Obstetric Variations of T. gondii and HIV-1 Co-infection among Pregnant Women in Cameroon

Abongwa

Signang

Tibi

et al. 2019

JAMB

View full text Add to dashboard Cite

show abstract

“…Corroborating many other studies, the use of untreated water was found to increase the risk of infection with T. gondii (Mwambe et al, 2013;Alsammani, 2014) through the ingestion of oocysts in contaminated water. A higher prevalence of T. gondii infection has been found among pregnant women who drink water from the well than those who drink piped water (Ishaku et al, 2009).…”

Section: Discussionmentioning

confidence: 57%

Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women attending antenatal care in Kigali, Rwanda

Murebwayire

Njanaake

Ngabonziza

et al. 2017

Tanzania J Hlth Res

View full text Add to dashboard Cite

Background: Toxoplasma gondii infection in pregnancy, if left untreated, is associated with spontaneous abortions, low birth weight babies, congenital deformities and intrauterine deaths. The infection is also associated with human immune deficiency virus/acquired immunodeficiency syndrome (HIV/AIDS). In Rwanda, the burden and risk factors of T. gondii infection among pregnant women and among HIV infected pregnant women is largely unknown. This cross-sectional study aimed at determining the seroprevalence of T. gondii infections and their risk factors among pregnant women in Kigali, Rwanda. Methods: Pregnant women aged 18 years and above who were attending antenatal care at four clinics in Kigali City, between April and August 2014 were screened for IgG and IgM antibodies against T. gondii using ELISA technique. Information on their HIV status and CD4 + cell count was obtained from their medical records. Participants were also interviewed on selected behaviours that predispose individuals to T. gondii infection. Results: A total of 384 pregnant women were involved in the study. The overall T. gondii seroprevalence was 12.2%. Of the 384 pregnant women studied, 37 (9.6%) were positive for anti-T.

show abstract

“…A recent review of studies exploring seroepidemiology and T. gondii ’s potential risk factors in various Arab and African contexts reached similar conclusions regarding the seroprevalence of T. gondii being significantly associated with a woman’s age. 41 For instance, Mwambe et al 44 reported that a woman’s risk of T. gondii infection increases by 7% with each additional year of age. The possible reasons for this remain unclear and require further exploration, but previous authors have suggested that it may be due to more prolonged exposure to the identified risk factors, transmission routes, and the generally low public awareness of preventive methods.…”

Section: Discussionmentioning

confidence: 99%

Seroprevalence of <em>Toxoplasma gondii</em> and its associated risk factors among women of reproductive age in Saudi Arabia: a systematic review and meta-analysis

Alzaheb

2018

IJWH

View full text Add to dashboard Cite

Toxoplasma gondii (T. gondii), which infects many warm-blooded animals including humans, causes toxoplasmosis, a globally widespread condition. To date, no research has explored the overall T. gondii infection seroprevalence among women in Saudi Arabia, nor have the risk factors associated with the infection been examined in the Saudi Arabian context. The present systematic review and meta-analysis therefore aimed to investigate toxoplasmosis seroprevalence based on previous study samples of Saudi women of reproductive age, and to establish the potentially risk factors in this national context. PubMed, Science Direct, and Scopus were searched for studies on T. gondii seroprevalence among women in mainland Saudi Arabia published between January 2000 and December 2017. Seroprevalence with 95% CI was presented for each study, and point estimates and their 95% CIs of pooled seroprevalence were then calculated. Twenty papers were eligible for inclusion, with samples totaling 13,597 females of childbearing age (ie, between 15 and 49 years) covering various regions of Saudi Arabia. The pooled estimation for T. gondii prevalence using a random-effect model was calculated as 27.8% (95% CI =20.6%–36.3%). A significant association was observed between age and T. gondii seroprevalence. This review represents the first comprehensive and systematic evaluation of T. gondii infection seroprevalence among Saudi Arabian women, and reports a high prevalence of Toxoplasma infection. Further research is required to support the development of more cost-effective preventive strategies.

show abstract

Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries

Cited by 33 publications

References 82 publications

Socio-demographic and Obstetric Variations of T. gondii and HIV-1 Co-infection among Pregnant Women in Cameroon

Socio-demographic and Obstetric Variations of T. gondii and HIV-1 Co-infection among Pregnant Women in Cameroon

Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women attending antenatal care in Kigali, Rwanda

Seroprevalence of <em>Toxoplasma gondii</em> and its associated risk factors among women of reproductive age in Saudi Arabia: a systematic review and meta-analysis

Contact Info

Product

Resources

About